Paul L Fidel Selected Research

Vaginitis

1/2019	Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".
1/2018	Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis.
1/2017	Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
4/2012	Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.
12/2010	Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.
11/2005	Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis.
10/2002	Candida-specific antibodies during experimental vaginal candidiasis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul L Fidel Research Topics

Disease

21	Infections 01/2020 - 10/2002
18	Candidiasis (Moniliasis) 01/2018 - 02/2002
9	Inflammation (Inflammations) 01/2021 - 01/2012
7	Vaginitis 01/2019 - 10/2002
7	Coinfection 01/2019 - 10/2002
6	Vulvovaginal Candidiasis 01/2021 - 04/2005
3	Sepsis (Septicemia) 10/2021 - 01/2019
3	COVID-19 11/2020 - 01/2020
3	Denture Stomatitis 01/2019 - 01/2016
2	Hypothermia 10/2021 - 01/2016
2	Rubella (German Measles) 11/2020 - 01/2020
2	Mumps 11/2020 - 01/2020
2	Measles 11/2020 - 01/2020
2	Intraabdominal Infections 01/2019 - 01/2018
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2018 - 02/2014
2	Bacterial Vaginosis 08/2007 - 02/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	HIV Infections (HIV Infection) 09/2020
1	Gingivitis 12/2019
1	Periodontal Diseases (Periodontal Disease) 12/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Cryptococcosis 07/2014
1	Vulvovaginitis 01/2014
1	Dyspareunia 01/2014
1	Nematode Infections 08/2013
1	Erythema 05/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 08/2007
1	Papillomavirus Infections 11/2005
1	Systemic candidiasis 08/2004
1	Warts (Wart) 08/2004
1	Hairy Leukoplakia 08/2004

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 10/2021 - 02/2002
5	AntibodiesIBA 11/2020 - 05/2002
4	VaccinesIBA 11/2020 - 02/2011
4	Dinoprostone (PGE2)FDA Link 01/2019 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2016
3	EicosanoidsIBA 01/2019 - 01/2018
3	AlarminsIBA 02/2014 - 01/2012
3	AntigensIBA 10/2003 - 10/2002
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2016
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 11/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 11/2020 - 10/2002
2	Immunologic Factors (Immunomodulators)IBA 09/2020 - 08/2007
2	Chelating AgentsIBA 01/2019 - 01/2018
2	IronIBA 01/2019 - 01/2018
2	3-hydroxypyridin-4-oneIBA 01/2019 - 01/2018
2	AzolesIBA 01/2019 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2018 - 02/2014
2	Antimicrobial PeptidesIBA 07/2014 - 03/2013
2	Calcium-Binding ProteinsIBA 09/2013 - 12/2010
2	ChemokinesIBA 08/2007 - 08/2004
1	Leukotriene E4IBA 01/2021
1	zafirlukast (Accolate)FDA LinkGeneric 01/2021
1	Leukotriene C4IBA 01/2021
1	Leukotriene B4IBA 01/2021
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021
1	LeukotrienesIBA 01/2021
1	montelukast (Singulair)FDA Link 01/2021
1	Leukotriene D4IBA 01/2021
1	Oxygen (Dioxygen)IBA 11/2020
1	COVID-19 VaccinesIBA 11/2020
1	BCG Vaccine FDA Link 01/2020
1	Attenuated VaccinesIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	L-161982IBA 01/2018
1	LigandsIBA 01/2017
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	InflammasomesIBA 04/2015
1	Interleukin-22 (IL-22)IBA 07/2014
1	Interleukin-17 (Interleukin 17)IBA 07/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Silicone Elastomers (SE 30)IBA 08/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2011
1	Anesthetics (Anesthetic Agents)IBA 12/2011
1	Peptides (Polypeptides)IBA 08/2010
1	Virulence Factors (Pathogenicity Factors)IBA 06/2008
1	Contraceptive Agents (Contraceptives)IBA 08/2007
1	Hormones (Hormone)IBA 08/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2005
1	Cadherins (E-Cadherin)IBA 06/2005
1	AgglutininsIBA 03/2005
1	RNA (Ribonucleic Acid)IBA 03/2005
1	Messenger RNA (mRNA)IBA 08/2004
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 08/2004
1	Metronidazole (Metric)FDA LinkGeneric 02/2004

Therapy/Procedure

4	Dentures 01/2019 - 05/2012
3	Highly Active Antiretroviral Therapy (HAART) 12/2019 - 08/2004
2	Therapeutics 10/2015 - 04/2015
1	Injections 11/2020
1	Contraindications 01/2020
1	Central Venous Catheters 01/2019
1	Contraception (Birth Control) 08/2007
1	Immunotherapy 11/2005